Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
Top Cited Papers
Open Access
- 1 May 2001
- Vol. 30 (3), 665-676
- https://doi.org/10.1016/s0896-6273(01)00317-8
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal DepletionJournal of Biological Chemistry, 1999
- Zinc-induced Alzheimer's Aβ1–40 Aggregation Is Mediated by Conformational FactorsJournal of Biological Chemistry, 1997
- Physical, Morphological and Functional Differences between pH 5.8 and 7.4 Aggregates of the Alzheimer's Amyloid Peptide A βJournal of Molecular Biology, 1996
- Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease BrainsJournal of Biological Chemistry, 1996
- Modified Amyloid β Protein Ending at 42 or 40 with Different Solubility Accumulates in the Brain of Alzheimer′s DiseaseBiochemical and Biophysical Research Communications, 1995
- Biochemical Evidence for the Long-Tail Form (Aβ1-42/43) of Amyloid β Protein as a Seed Molecule in Cerebral Deposits of Alzheimer′s DiseaseBiochemical and Biophysical Research Communications, 1994
- Rapid induction of Alzheimer A beta amyloid formation by zincScience, 1994
- Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.Journal of Epidemiology and Community Health, 1975
- Prophylactic value of clioquinol against travellers' diarrhœaThe Lancet, 1971